Alopecia Areata

Improving Disease Severity

Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US

A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata

Long-Term PF-06651600 for the Treatment of Alopecia Areata

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)

Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia Areata

TREg Activation in the Treatment of the PELADE (Alopecia Areata)

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Topical Methotrexate vs Minoxidil for Localized Alopecia Areata

Association of TLR7 Gene rs3853839 Polymorphism With Disease Severity in Alopecia Areata: A Case-Control Study

Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia Areata

Litfulo Capsules Special Investigation

Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

Dupilumab in the Treatment of Pediatric Alopecia Areata

A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)

CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry